Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

59 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Eligibility NCT01232452 Non-Small-Cell Lung Carcinoma - Eligibility

- 27/09/21 - 1 modulo, 2 itemgroups, 37 elementi, 2 lingue
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01232452

Eligibility NCT01085136 Carcinoma, Non-Small-Cell Lung - Eligibility

- 27/09/21 - 1 modulo, 2 itemgroups, 30 elementi, 2 lingue
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01085136

Eligibility Lung Cancer NCT00955175

- 20/09/21 - 1 modulo, 1 ItemGroup, 11 elementi, 1 linguaggio
ItemGroup: Criteria
Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09; ODM derived from: https://clinicaltrials.gov/show/NCT00955175

Eligibility NCT00858364 Non-Small Cell Lung Cancer - Eligibility

- 20/09/21 - 1 modulo, 2 itemgroups, 33 elementi, 2 lingue
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00858364

Lung Cancer NCT01041781 Registration - CALGB-30801 Registration Worksheet Form - 2891095v1.0 - CALGB-30801 Registration Worksheet Form

- 20/09/21 - 1 modulo, 9 itemgroups, 36 elementi, 1 linguaggio
Itemgroups: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Patient Demographics/Pre-Treatment Characteristics3, Certification Of Eligibility, Protocol Design, Companion Study, Registration Information
CALGB-30801 Registration Worksheet Form Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6AF26CA3-DB68-EEE0-E040-BB89AD436D54

E5508 On-Study Form NCT01107626

- 20/09/21 - 1 modulo, 13 itemgroups, 75 elementi, 1 linguaggio
Itemgroups: Header Module, Patient demographics, Data amendment, Pre-Treatment Characteristics, Pre-Treatment Characteristics1, Advanced NSCLC Disease Description, Metastatic Site, Medical History, Pre-Registration Hematology/Chemistry, Advanced NSCLC Prior Treatment, NSCLC Brain Metastases, Baseline Abnormalities, Comments
E5508 On-Study Form NCT01107626 Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6D435D37-5591-AA13-E040-BB89AD43538D

Lung Cancer NCT00946712 Pre-Study - Southwest Oncology Group S0819 Prestudy Form - 2863901v1.0 - Southwest Oncology Group S0819 Prestudy Form

- 20/09/21 - 1 modulo, 8 itemgroups, 72 elementi, 1 linguaggio
Itemgroups: Header Module, PATIENT AND DISEASE DESCRIPTION, PATIENT AND DISEASE DESCRIPTION1, LABORATORY VALUES, LABORATORY VALUES1, ADDITIONAL PRESTUDY DATA, PRIOR TREATMENT RELATED TO THIS CANCER, Comments
Southwest Oncology Group S0819 Prestudy Form Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=684FE956-5AAF-A7DA-E040-BB89AD432A2B

Lung Cancer NCT00863512 Pre-Study - CALGB 30506 Pre-Study/Surgical Resection Form - 2821782v1.0 - CALGB 30506 Pre-Study/Surgical Resection Form

- 20/09/21 - 1 modulo, 9 itemgroups, 46 elementi, 1 linguaggio
Itemgroups: Header Module, Header, Initial Laboratory Values, Smoking Status, Pre-surgical Disease Status, Surgical Disease Status, Planned Treatment, Contact Information, Footer Module
CALGB 30506 Pre-Study/Surgical Resection Form Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5FE8C8A3-6705-BC07-E040-BB89AD4332A8

On-Study - Phase II Lung Cancer - NSCLC Advanced On-Study Form - 2398811v1.0 - Phase II Lung Cancer - NSCLC Advanced On-Study Form

- 20/09/21 - 1 modulo, 8 itemgroups, 55 elementi, 1 linguaggio
Itemgroups: CRF Header, Pre-Treatment Characteristics , Disease Description NSCLC ADVANCED, Prior Treatment - NSCLC Advanced, Prior Systemic Therapy NSCLC Advanced, Surgical Procedure Description , Prior Radiation Therapy - NSCLC Advanced, Comments
Phase II Consortium - Phase II Lung Cancer - NSCLC Advanced On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF7A9F25-B26C-5224-E034-0003BA3F9857

On-Study Form NSCLC Stage I-III

- 20/09/21 - 1 modulo, 8 itemgroups, 65 elementi, 1 linguaggio
Itemgroups: CRF Header, Pre-Treatment Characteristics , Disease Description - Stage I-III, Prior Treatment NSCLC Stage I-III, Prior Systemic Therapy NSCLC Advanced, Surgical Procedure Description , Prior Radiation Therapy NSCLC Advanced, Comments
Phase II Consortium - Phase II Lung Cancer - NSCLC Stage I-III On-Study Form (for Adjuvant Studies and Inoperable Stage III) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF3F2FE3-D320-46AD-E034-0003BA3F9857

Lung Cancer NCT01107626 Eligibility - E5508 Registration Worksheet (step 2) - 3078042v1.0 - E5508 Registration Worksheet (step 2)

- 17/09/21 - 1 modulo, 3 itemgroups, 19 elementi, 1 linguaggio
Itemgroups: Eligibility, Demographic Data Required For Patient Registration, I have reviewed the above data and agree the date are accurate and correct
E5508 Registration Worksheet (step 2) Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8528E45F-A327-F490-E040-BB89AD4356FC

Eligibility NCT00981058 Non Small Cell Lung Cancer - Eligibility

- 17/09/21 - 1 modulo, 2 itemgroups, 30 elementi, 2 lingue
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00981058

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial